VBL Therapeutics to Present Data on its Novel VB-600 Platform at Keystone Conference on February 26

*Oral Presentation Details:*
Title:		MOSPD2: Key Regulator of Myeloid Cell Migration and a Novel Target for Treatment of Inflammatory Diseases
Presenter:		Itzhak Mendel, PhD
Date:		Tuesday, February 26, 2019
Time:		8:00 – 11:00 AM MST
Session:		Myeloid Cells in Metabolic and Inflammatory Diseases
Location:		Eldorado Grand Ballroom

*Poster Presentation Details:*
*Abstract:*		MOSPD2: Key Regulator of Myeloid Cell Migration and a Novel Target for Treatment of Inflammatory Diseases
Session title:		Poster Session 2
Date:		Tuesday, February 26, 2019
Time:		7:30 - 10:00 PM MST
Poster #:		2028

For more information on the Keystone Symposium on Myeloid Cells, including a detailed program, refer to http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1553

Investor Calendar